Sage Journals: Discover world-class research

Open access

Research article

First published 2018-10

Prevalence and correlates of stimulant and depressant pharmacological cognitive enhancement among Norwegian students

Helga Myrseth, Ståle Pallesen, Torbjørn Torsheim [...]

Nordic Studies on Alcohol and Drugs

Retricted access

Research article

First published 2022-6

Predictors of Attitudes Toward Pharmacological Cognitive Enhancers in College Students

Lisa J. Hayes, R. Brooke Bays, Sydney Arthur [...]

Emerging Adulthood

Open access

Research article

First published 2017-2

Sleep Deprivation Impairs and Caffeine Enhances My Performance,but Not Always Our Performance

Nadira S. Faber, Jan A. Häusser, Norbert L. Kerr

Personality and Social Psychology Review

Open access

Research article

First published 2010-1-7

Complex Antioxidant Blend Improves Memory in Community-Dwelling Seniors

William K. Summers, Roy L. Martin, Michael Cunningham [...]

Journal of Alzheimer’s Disease

Retricted access

Research article

First published 2019-12

Beyond Treatment Versus Enhancement: A Qualitative Study of Pharmacological Neuro-Enhancement Among Dutch and Lithuanian University Students

Aleksi Hupli, Gabija Didžiokaitė, Marte Ydema

Contemporary Drug Problems

Retricted access

Research article

First published 2008

Estimation of Working Memory in Macaques for Studying Drugs for the Treatment of Cognitive Disorders

Jerry J. Buccafusco

Journal of Alzheimer’s Disease

Retricted access

Research article

First published 2011-12

Why Aren’t We Smarter Already

Thomas Hills, Ralph Hertwig

Current Directions in Psychological Science

Open access

Research article

First published 2025

How to advance the pharmacological management of cognitive impairment in Parkinson's disease

Carla Abdelnour, Lucy L Gibson, Lucia Batzu [...]

Journal of Parkinson’s Disease

Open access

Review article

First published 2019

Neuroethical issues in cognitive enhancement: Modafinil as the example of a workplace drug?

Annette B. Brühl, Camilla d’Angelo, Barbara J. Sahakian

Brain and Neuroscience Advances

Retricted access

Review article

First published 2014-10-10

Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014

Wolfgang Froestl, Andrea Pfeifer, Andreas Muhs

Journal of Alzheimer’s Disease

Search results